Neogen Analyst Price Targets - Benzinga

Neogen Corp

NEOGNASDAQ

Trade with Public

Trade with Public

$12.37

0.131.02%

마지막 업데이트: Oct 2, 2:47 PM

$12.39

0.151.23%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

© 2026 Benzinga | All Rights Reserved

Neogen Analyst Price Targets

Wall Street analyst price targets and consensus rating for Neogen (NEOG).

Price Target Range — 11 Quarters

Analyst Consensus — 4 Analysts

1S.Buy

2Buy

1Hold

Consensus RatingMarket Outperform# Analysts4Avg. Consensus PT$13Upside to Avg. PT+2.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 30, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$12→$14
Aug 26, 2026	Piper Sandler	David Westenberg	Upgrade	Neutral→Overweight	$13→$14
Aug 3, 2026	Piper Sandler	David Westenberg	PT Raise	Neutral	$11→$13
Jan 12, 2026	Piper Sandler	David Westenberg	PT Raise	Neutral	$7→$10
Jan 9, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$8→$12
Dec 10, 2025	CJS Securities	Robert Labick	Upgrade	Market Perform→Market Outperform	$10
Oct 16, 2025	Piper Sandler	David Westenberg	PT Raise	Neutral	$5→$7
Sep 29, 2025	CJS Securities	Robert Labick	Initiate	Market Perform	$10
Jul 29, 2025	William Blair	Brandon Vazquez	Downgrade	Outperform→Market Perform	—
Jun 30, 2025	Guggenheim	Subbu Nambi	PT Cut	Buy	$13→$10
Apr 22, 2025	Piper Sandler	David Westenberg	PT Cut	Neutral	$6→$5
Apr 14, 2025	Piper Sandler	David Westenberg	PT Cut	Neutral	$13→$7
Apr 10, 2025	Guggenheim	Subbu Nambi	PT Cut	Buy	$15→$13
Jan 21, 2025	Piper Sandler	David Westenberg	PT Cut	Neutral	$17→$13
Dec 19, 2024	Guggenheim	Subbu Nambi	Initiate	Buy	$15
Aug 6, 2024	Piper Sandler	David Westenberg	PT Raise	Neutral	$17→$18
Apr 15, 2024	Piper Sandler	David Westenberg	PT Cut	Neutral	$19→$17
Jan 18, 2024	Piper Sandler	David Westenberg	PT Raise	Neutral	$18→$19
Oct 16, 2023	Piper Sandler	David Westenberg	PT Cut	Neutral	$24→$18

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Guggenheim Maintains Buy on Neogen, Raises Price Target to $14

Guggenheim analyst Subbu Nambi maintains Neogen (NASDAQ:NEOG) with a Buy and raises the price target from $12 to $14.

Benzinga Newsdesk

PRO
Watching Neogen; Traders Circulate Unconfirmed Analyst Report Defending NEOG After Sell-Off, Says Product Is Third-Party Manufactured, Revenue Impact Immaterial And FDA Dialogue Ongoing

Benzinga Newsdesk

Neogen Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Neogen will report Q1 earnings Oct. 6, with EPS forecast at 5 cents and revenue at $208.18M; analysts recently raised ratings and targets.

Avi Kapoor

PRO
Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14

Piper Sandler analyst David Westenberg upgrades Neogen (NASDAQ:NEOG) from Neutral to Overweight and raises the price target from $13 to $14.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Neutral on Neogen, Raises Price Target to $13

Piper Sandler analyst David Westenberg reiterates Neogen (NASDAQ:NEOG) with a Neutral and raises the price target from $11 to $13.

Benzinga Newsdesk

Neogen Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Neogen Corporation (NASDAQ: NEOG) to release Q3 earnings on April 9. Analysts expect 5 cents/share, down from 10 cents last year. Stock rose 1.6% on Monday.

Avi Kapoor